Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial

Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A minor site maintenance update was applied (Revision: v3.4.2) and the earlier Revision: v3.4.1 notice was removed, along with a banner about government funding status. There are no substantive changes to the study details, eligibility criteria, or other critical information; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:57:27.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and operating status, plus related topics such as MedlinePlus Genetics and a page revision identifier (v3.4.1). The core study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.6%
    Check dated 2026-02-04T00:47:25.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a glossary toggle, updated QC metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision to v3.4.0; removed the older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' and the older revision label v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:30:48.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Multiple Myeloma is no longer listed as a condition on the study page, and the related topics section (MedlinePlus Genetics) has been removed. This removes key contextual information about the disease and related resources for the trial.
    Difference
    0.2%
    Check dated 2026-01-20T19:24:45.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a related topic and linked MedlinePlus Genetics resources; the revision note updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-13T17:46:54.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added a Locations section with new study sites in Illinois, Oregon, Pennsylvania, Tennessee, New South Wales, Victoria, Ontario, Barcelona, and Navarre. Updated the revision to v3.3.3 and removed older related topics such as MedlinePlus Genetics and the term 'Multiple myeloma' from related topics.
    Difference
    1%
    Check dated 2025-12-23T08:22:51.000Z thumbnail image

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.